Two members of the Murtaza Lab at the Center for Human Genetics and Precision Medicine (CHGPM) recently showcased their innovative research at the American Association for Cancer Research (AACR) Annual Meeting 2025.
Elise Dietmann, an undergraduate researcher, presented her work on genomics-enabled cancer diagnostics, contributing to the lab’s mission of advancing precision oncology through novel molecular approaches.
Muhammad Talha Nawaz,MBBS/MD a clinical research fellow, presented findings from his pilot study evaluating tumor DNA detection in peritoneal fluid. His research explores new methods for monitoring peritoneal metastasis in patients undergoing intra-peritoneal chemotherapy.
Their participation at AACR highlights the Murtaza Lab’s commitment to translational cancer research and the impactful contributions of both emerging and established scientists within CHGPM.